"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 6 | 6 |
| 2014 | 1 | 9 | 10 |
| 2015 | 0 | 6 | 6 |
| 2016 | 0 | 22 | 22 |
| 2017 | 2 | 297 | 299 |
| 2018 | 3 | 311 | 314 |
| 2019 | 1 | 100 | 101 |
| 2020 | 0 | 27 | 27 |
| 2021 | 0 | 25 | 25 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice. Drug Deliv. 2021 Dec; 28(1):1150-1165.
-
Phlyctenular Keratoconjunctivitis in a Patient With COVID-19 Infection. Cornea. 2021 Nov 01; 40(11):1502-1504.
-
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacol Res Perspect. 2021 10; 9(5):e00842.
-
Management of anaphylaxis in children undergoing oral food challenges in an adapted COVID-19 field hospital. Arch Dis Child. 2021 12; 106(12):e52.
-
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey. Int J Gynecol Cancer. 2021 10; 31(10):1363-1368.
-
COVID-19 vaccine-induced Stevens-Johnson syndrome. Clin Exp Dermatol. 2021 Dec; 46(8):1615-1617.
-
Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics. BMC Pulm Med. 2021 Aug 17; 21(1):268.
-
Pharmacotherapy of atrial fibrillation in COVID-19 patients. Cardiol J. 2021; 28(5):758-766.
-
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. 2021 08 10; 326(6):490-498.
-
Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine. Cornea. 2021 08 01; 40(8):1070-1072.